Prevention of Cardiovascular Disease – Will We Ever Have Time?
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
In recent years, the rapidly growing incidence of cardiovascular diseases, which are beginning to appear in younger people. There is a need for the primary prevention of cardiovascular disease, i.e. measures to prevent the occurrence of heart disease in healthy people.
However, adherence to medication therapy, prescribed as primary prevention, our population is very low. Development of adverse reactions to medication drugs as they are hypersensitive, allergic addiction, negative reaction on the part of other organs and systems, significantly reduces the effectiveness of treatment.
The way out of this situation may be drugs of medicinal plants, which continue to play a significant role in the arsenal of therapeutic agents. For example, patients with neuro dystonia is considered an advantage of prevention with the use of traditional medicines, the effect of which is aimed at the normalization of the nervous system.
One such drug is Neokardil. Correction of functional changes and move them into organic when NDCs via Neokardin can play a significant role in the prevention of cardiovascular disease.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
